The safety and efficacy of systemic delivery of a new liver-de-targeted TGFβ signaling inhibiting adenovirus in an immunocompetent triple negative mouse mammary tumor model

Cancer Gene Therapy, Published online: 24 January 2024; doi:10.1038/s41417-024-00735-1The safety and efficacy of systemic delivery of a new liver-de-targeted TGFβ signaling inhibiting adenovirus in an immunocompetent triple negative mouse mammary tumor model

Source: Cancer Gene Therapy - January 24, 2024 Category: Cancer & Oncology Authors: Soon Cheon Shin Renee E. Vickman Beniamin Filimon Yuefeng Yang Zebin Hu Kathy A. Mangold Bellur S. Prabhakar Hans Schreiber Weidong Xu Source Type: research